Who owns Biogen (BIIB)? Superinvestor holders
4 superinvestors of the 157 tracked here hold Biogen (BIIB) in their latest 13F filing, with $3.7B between them. Primecap team gives it the most weight: 2.13% of the reported portfolio. In their latest reported quarter, Primecap team and Andrew Spokes added; Samantha McLemore and Joel Greenblatt reduced.
Sarah Ketterer and Larry Robbins sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 4 of 157
- Biggest holder
- Primecap team, $3.4B
- Largest weight
- Primecap team, 2.13%of their portfolio
- Combined value
- $3.7B
- Bought last quarter
- 2
- Sold last quarter
- 4
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Primecap teamPrimecap Management | 2.13% | $3.4B | 15.2M | ▲ Added 0.3% | +42.43K | Q3 2026 |
| 2 | Samantha McLemorePatient Capital Management | 1.87% | $55.7M | 246.48K | ▼ Reduced 13% | −37.22K | Q3 2026 |
| 3 | Andrew SpokesFarallon Capital Management | 0.80% | $153.8M | 680.87K | ▲ Added 859% | +609.87K | Q3 2026 |
| 4 | Joel GreenblattGotham Asset Management | 0.14% | $60.5M | 279.9K | ▼ Reduced 6.2% | −18.53K | Q2 2026 |
Sold out last quarter
- Sarah Kettererwas $60.1M · Q3 2026
- Larry Robbinswas $10.5M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 3 | 16.12M | $3.6B | 2 | 2 |
| Q2 2026 | 157 | 5 | 16.07M | $3.5B | 2 | 4 |
| Q1 2026 | 157 | 6 | 16.58M | $3B | 1 | 5 |
| Q4 2025 | 157 | 7 | 20.36M | $3.6B | 4 | 4 |
| Q3 2025 | 157 | 6 | 21.03M | $2.9B | 4 | 2 |
| Q2 2025 | 157 | 6 | 22.86M | $2.9B | 3 | 3 |
| Q1 2025 | 156 | 7 | 21.47M | $2.9B | 4 | 4 |
| Q4 2024 | 156 | 6 | 20.4M | $3.1B | 5 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Primecap team | 15.2M | 15.15M | 14.76M | 14.76M | 14.95M | 15.8M | 15.94M | 16.05M |
| Andrew Spokes | 680.87K | 71K | — | — | — | — | — | — |
| Samantha McLemore | 246.48K | 283.7K | 379.74K | 576.35K | 396.65K | 320.47K | 455.61K | 413.96K |
| Joel Greenblatt | · | 279.9K | 298.44K | 276.81K | 270.5K | — | — | — |
| Sarah Ketterer | — | 278.28K | 280.78K | 521.1K | 567.52K | 493.36K | 433.52K | 281.7K |
| Steve Cohen | · | — | 809.62K | 2.81M | 3.87M | 3.83M | — | — |
| Larry Robbins | · | — | 57.02K | 290.61K | — | — | — | — |
| Israel Englander | · | — | — | 1.13M | — | — | — | — |
| Jim Simons (1938–2024) | — | — | — | — | 964.41K | 1.05M | 804.51K | 1.19M |
| David Shaw (founder) | · | — | — | — | — | 1.37M | 1.59M | 1.61M |
| Cliff Asness | · | — | — | — | — | — | 1.37M | — |
| John Overdeck and David Siegel (founders) | — | — | — | — | — | — | 879.33K | 852.34K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own BIIB?
In their latest 13F filings: Primecap team (2.13% of the portfolio, $3.4B), Samantha McLemore (1.87% of the portfolio, $55.7M), Andrew Spokes (0.80% of the portfolio, $153.8M), Joel Greenblatt (0.14% of the portfolio, $60.5M).
Who bought BIIB last quarter?
Primecap team (added 0.3%), Andrew Spokes (added 859%). “Last quarter” is each investor's latest reported quarter.
Who sold BIIB last quarter?
Reduced: Samantha McLemore (13% fewer shares), Joel Greenblatt (6.2% fewer shares). Sold out entirely: Sarah Ketterer (was $60.1M), Larry Robbins (was $10.5M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Biogen (BIIB)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/BIIB/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to BIIB by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.